Allocetra for Knee Arthritis

This trial tests Allocetra, an experimental therapy, to determine its effectiveness for knee osteoarthritis (OA), a condition causing joint pain and stiffness. The trial compares Allocetra injections directly into the knee with placebo injections to evaluate which is more effective. Individuals with moderate to severe knee OA, who have tried at least two other treatments without success and experience knee pain, might be suitable candidates for this study. As a Phase 2 trial, the research focuses on assessing the treatment's effectiveness in an initial, smaller group of participants.

The trial requires participants to stop taking certain pain medications before the screening period and to avoid certain medications during the trial. However, the specific medications you need to stop are not detailed in the information provided.

Research has shown that Allocetra is safe for treating knee osteoarthritis. In past studies, including one with multiple injections, participants generally tolerated the treatment well. No serious side effects occurred during or after the treatment.

Allocetra is unique because it represents a novel approach to treating knee arthritis with its focus on modulating the immune response. Unlike standard treatments like NSAIDs or corticosteroids, which mainly address pain and inflammation, Allocetra works by targeting the root cause of inflammation through its cellular mechanism. This treatment involves intra-articular injections directly into the knee, potentially offering more localized and effective relief by harnessing the body's own immune system to promote healing. Researchers are excited about Allocetra because it could provide longer-lasting benefits with fewer side effects compared to current therapies.

Research has shown that Allocetra, which participants in this trial may receive, may help treat knee osteoarthritis (OA). In studies, patients using Allocetra reported a 42% improvement in knee joint function, along with noticeable reductions in stiffness and pain. These findings suggest that Allocetra could ease daily activities for people with knee OA. Additionally, data indicates a 47% improvement in stiffness and function scores, highlighting its potential as an effective treatment. Overall, early results are promising, suggesting that Allocetra might provide real relief for those dealing with knee osteoarthritis.¹²³⁶⁷